CereVasc is based in Charlestown, Massachusetts. It has raised $85M in total funding. Latest round: Series C.
CereVasc funding overview
CereVasc is based in Charlestown, Massachusetts. CereVasc has raised $85M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in June 2026. The round record for CereVasc runs through 2026; nothing later has been disclosed. Investors on record include Piper Sandler Merchant Banking, Johnson & Johnson Innovation – JJDC, Inc., Medtronic, Bain Capital Life Sciences, Perceptive Xontogeny Venture Funds. 5 distinct backers are named across the disclosed rounds.
CereVasc at a glance
Total raised
$85M
Latest round
Series C
Latest round date
June 2026
Headquarters
Charlestown, Massachusetts
Notable investors
Piper Sandler Merchant Banking, Johnson & Johnson Innovation – JJDC, Inc., Medtronic, Bain Capital Life Sciences, Perceptive Xontogeny Venture Funds
Frequently asked about CereVasc funding
How much has CereVasc raised?
CereVasc has raised $85M in total disclosed funding across the rounds on record.
Who has invested in CereVasc?
Piper Sandler Merchant Banking, Johnson & Johnson Innovation – JJDC, Inc., Medtronic, Bain Capital Life Sciences, Perceptive Xontogeny Venture Funds are named among the investors backing CereVasc.
What was the latest CereVasc funding round?
The most recent disclosed round is a Series C, announced in June 2026.
Where is CereVasc based?
CereVasc is based in Charlestown, Massachusetts.
When did CereVasc last raise?
The last disclosed CereVasc round closed in June 2026 at Series C.
Totals shown for CereVasc aggregate every disclosed round on file. To see how that compares, browse the companies in Charlestown and the investors behind them below.
